The Ausonex™ OneStep is a state-of-the-art technology used to provide a rapid, robust and accurate evaluation of a subject’s ability to hear. This technology is especially appropriate in subjects, such as newborn infants, who are unable to respond to conventional behavioural testing.

Currently there are two ways of screening for hearing impairment in newborn infants. One method, called the Automated Auditory Brainstem Response (AABR), is accurate, but relatively slow. The other method, based on Otoacoustic Emissions (OAE), is quicker, but less accurate. The Ausonex™ OneStep technology combines the best of both worlds – it is a next-generation Automated Auditory Brainstem Response (AABR) device that measures the brain’s response to a unique acoustic stimulus.

This technology provides two significant advantages over current AABR devices:

  1. Ultra-fast ABR waveform acquisition means that testing can be completed quicker than ever before, often in only 5 to 10 seconds;
  2. Ultra-fast ABR acquisition combined with automated ABR detection and analysis means that a much more comprehensive and accurate hearing assessment never available before can be performed.

.

The Ausonex™ OneStep technology provides unprecedented speed and accuracy in hearing screening. It is the only system in the world that provides ultra-fast ABR acquisition together with both fully automated waveform detection and analysis. This provides, for the first time, a system that delivers a complete picture of the hearing physiology of each and every subject.

Effective utilisation of the Ausonex™ OneStep technology can provide a number of significant benefits. Typically these include:

  • Reduced Test Times;
  • Improved Accuracy;
  • Improved Robustness to movement (myogenic) artefacts;
  • Reduced costs of hearing screening programs.

Ausonex™ is currently commercialising the OneStep technology in collaboration with a number of Hospitals, Birthing centres, and Audiology clinics throughout Australasia, South East Asia and Europe.

Other applications for the Ausonex™ OneStep technology exist in areas such as: diagnostic audiology; the detection of acquired hearing loss in adults; and veterinary applications such as hearing screening in pure bred animals and ototoxity testing.

to top

 


 
© copyright 2007 Ausonex Pty Ltd